ArticleMedicine2021

EphA2, vascular endothelial growth factor, and vascular endothelial growth factor correlate with adverse outcomes and poor survival in patients with glioma.

Likui Shen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.